Factors influencing implementation of personalized prevention plans among annual wellness visit patients using the theory of planned behavior : A quantitative study
Copyright © 2021 Elsevier Inc. All rights reserved..
BACKGROUND: The Affordable Care Act provides Medicare Part B beneficiaries access to cost-free Annual Wellness Visits (AWVs). Patients receive health behavior recommendations from a Personalized Prevention Plan (PPP) during AWV encounters.
AIMS: To identify factors clinical pharmacists can use to influence adoption of PPPs in primary care practices.
METHOD: Utilizing a cross-sectional design, 77 Medicare patients (mean age 74.05 ± 8.04 years) presenting for subsequent AWV completed a theory of planned behavior (TPB) based questionnaire at two primary care practices.
RESULTS: 66.2% reported they were in the process of implementing PPPs and 51.9% reported implementing recommendations in the previous 12 months. TPB constructs accounted for 35.8% (p < .001) of the variation in intention, with subjective norm (SN) (β = 0.359, p = 0.004) as the strongest determinant, followed by attitude (β = 0.195, p = 0.093), and perceived behavioral control (PBC) (β = 0.103, p = 0.384). Intention accounted for 27.1% of the variance for implementing PPPs and was not a significant determinant (β = 0.047, p = 0.917). Addition of past behavior with TPB constructs significantly improved the predictability of the TPB model, accounted for 55% of the variation in intention (p < .001), and demonstrated a significant positive influence (β = 0.636, p < 0.001) on future PPP implementations.
DISCUSSION: This study demonstrates utility of the TPB in predicting implementation of PPPs.
CONCLUSIONS: Clinical pharmacists positioned as providers of AWVs can strengthen intention to adopt PPPs by integrating referents into AWV processes, and evaluating past behavior trends to improve future PPP implementation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Research in social & administrative pharmacy : RSAP - 17(2021), 9 vom: 01. Sept., Seite 1636-1644 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Malcolm, O'Neal [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 02.08.2021 Date Revised 02.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.sapharm.2021.01.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322358191 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322358191 | ||
| 003 | DE-627 | ||
| 005 | 20231225181855.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.sapharm.2021.01.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1074.xml |
| 035 | |a (DE-627)NLM322358191 | ||
| 035 | |a (NLM)33678585 | ||
| 035 | |a (PII)S1551-7411(21)00022-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Malcolm, O'Neal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factors influencing implementation of personalized prevention plans among annual wellness visit patients using the theory of planned behavior |b A quantitative study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.08.2021 | ||
| 500 | |a Date Revised 02.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The Affordable Care Act provides Medicare Part B beneficiaries access to cost-free Annual Wellness Visits (AWVs). Patients receive health behavior recommendations from a Personalized Prevention Plan (PPP) during AWV encounters | ||
| 520 | |a AIMS: To identify factors clinical pharmacists can use to influence adoption of PPPs in primary care practices | ||
| 520 | |a METHOD: Utilizing a cross-sectional design, 77 Medicare patients (mean age 74.05 ± 8.04 years) presenting for subsequent AWV completed a theory of planned behavior (TPB) based questionnaire at two primary care practices | ||
| 520 | |a RESULTS: 66.2% reported they were in the process of implementing PPPs and 51.9% reported implementing recommendations in the previous 12 months. TPB constructs accounted for 35.8% (p < .001) of the variation in intention, with subjective norm (SN) (β = 0.359, p = 0.004) as the strongest determinant, followed by attitude (β = 0.195, p = 0.093), and perceived behavioral control (PBC) (β = 0.103, p = 0.384). Intention accounted for 27.1% of the variance for implementing PPPs and was not a significant determinant (β = 0.047, p = 0.917). Addition of past behavior with TPB constructs significantly improved the predictability of the TPB model, accounted for 55% of the variation in intention (p < .001), and demonstrated a significant positive influence (β = 0.636, p < 0.001) on future PPP implementations | ||
| 520 | |a DISCUSSION: This study demonstrates utility of the TPB in predicting implementation of PPPs | ||
| 520 | |a CONCLUSIONS: Clinical pharmacists positioned as providers of AWVs can strengthen intention to adopt PPPs by integrating referents into AWV processes, and evaluating past behavior trends to improve future PPP implementation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Annual wellness visits | |
| 650 | 4 | |a Chronic care management | |
| 650 | 4 | |a Clinical pharmacists | |
| 650 | 4 | |a Decision support | |
| 650 | 4 | |a Disease prevention | |
| 650 | 4 | |a Geriatric | |
| 650 | 4 | |a Health behaviors | |
| 650 | 4 | |a Health education | |
| 650 | 4 | |a Health promotion | |
| 650 | 4 | |a Personalized prevention plan | |
| 650 | 4 | |a Primary care practices | |
| 650 | 4 | |a Quality improvement | |
| 650 | 4 | |a Theory of planned behavior | |
| 700 | 1 | |a Nelson, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Modeste, Naomi N |e verfasserin |4 aut | |
| 700 | 1 | |a Gavaza, Paul |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Research in social & administrative pharmacy : RSAP |d 2005 |g 17(2021), 9 vom: 01. Sept., Seite 1636-1644 |w (DE-627)NLM166902047 |x 1934-8150 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2021 |g number:9 |g day:01 |g month:09 |g pages:1636-1644 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.sapharm.2021.01.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 9 |b 01 |c 09 |h 1636-1644 | ||